Position in TGTX
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$34,117
+$13,488 QoQ
Shares Held
621
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#349
of 425 holders
Holding Since
Dec 2024
6 quarters on record
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Main Street Group, LTD holds $88,483 across 8 Biotechnology names. TGTX ranks #1 (38.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
This page
|
621 | $34,117 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
70 | $17,133 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25 | $12,418 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
100 | $7,929 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
100 | $7,448 | |
| 6 | ATAI |
AtaiBeckley Inc.
|
1,000 | $5,270 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
62 | $3,381 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
90 | $787 |
All Filings in TGTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,117 | 621 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $20,629 | 621 | Shares | Sole | 2026-05-06 | |
| 2025-09-30 | $5,780 | 160 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $5,758 | 160 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $6,308 | 160 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,816 | 160 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||